148 related articles for article (PubMed ID: 15674913)
1. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.
Akobeng AK; Gardener E
Cochrane Database Syst Rev; 2005 Jan; (1):CD003715. PubMed ID: 15674913
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis.
Aruljothy A; Singh S; Narula N; Moran GW; Vuyyuru SK; Hogan M; Zayadi A; MacDonald JK; Caron B; Danese S; Peyrin Biroulet L; Ma C; Jairath V
Aliment Pharmacol Ther; 2023 Oct; 58(8):740-762. PubMed ID: 37589498
[TBL] [Abstract][Full Text] [Related]
3. Maintaining remission in Crohn's disease post surgery: what can we learn from Cochrane?
Gordon M
Frontline Gastroenterol; 2024 May; 15(3):241-246. PubMed ID: 38665790
[TBL] [Abstract][Full Text] [Related]
4. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Naidoo K; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190
[TBL] [Abstract][Full Text] [Related]
6. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.
Akobeng AK; Zhang D; Gordon M; MacDonald JK
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003715. PubMed ID: 27681657
[TBL] [Abstract][Full Text] [Related]
7. The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease.
Schoepfer AM; Bortolotti M; Pittet V; Mottet C; Gonvers JJ; Reich O; Fournier N; Vader JP; Burnand B; Michetti P; Froehlich F
Aliment Pharmacol Ther; 2014 Oct; 40(8):930-7. PubMed ID: 25146487
[TBL] [Abstract][Full Text] [Related]
8. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
9. Interventions for prevention of post-operative recurrence of Crohn's disease.
Doherty G; Bennett G; Patil S; Cheifetz A; Moss AC
Cochrane Database Syst Rev; 2009 Oct; (4):CD006873. PubMed ID: 19821389
[TBL] [Abstract][Full Text] [Related]
10. Management of Crohn's disease in adults.
Lichtenstein GR; Hanauer SB; Sandborn WJ;
Am J Gastroenterol; 2009 Feb; 104(2):465-83; quiz 464, 484. PubMed ID: 19174807
[TBL] [Abstract][Full Text] [Related]
11. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
14. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2012 Nov; 11():CD004118. PubMed ID: 23152224
[TBL] [Abstract][Full Text] [Related]
15. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
16. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
Dignass A; Van Assche G; Lindsay JO; Lémann M; Söderholm J; Colombel JF; Danese S; D'Hoore A; Gassull M; Gomollón F; Hommes DW; Michetti P; O'Morain C; Oresland T; Windsor A; Stange EF; Travis SP;
J Crohns Colitis; 2010 Feb; 4(1):28-62. PubMed ID: 21122489
[No Abstract] [Full Text] [Related]
17. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Wang Y; Parker CE; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
[TBL] [Abstract][Full Text] [Related]
18. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
19. 5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations.
Nguyen GC; Gulamhusein A; Bernstein CN
Am J Gastroenterol; 2012 Sep; 107(9):1298-304; quiz 1297, 1305. PubMed ID: 22751467
[TBL] [Abstract][Full Text] [Related]
20. The long-term effect on surgery-free survival of biological compared to conventional therapy in Crohn's disease in real world-data: a retrospective study.
Valvano M; Vinci A; Cesaro N; Frassino S; Ingravalle F; Ameli M; Viscido A; Necozione S; Latella G
BMC Gastroenterol; 2023 Dec; 23(1):438. PubMed ID: 38097975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
